Post Authorisation Safety Study (PASS): an European observational cohort of patients with type 1 diabetes treated via intraperitoneal route with Insuman Implantable 400 IU/mL in Medtronic MiniMed implantable pump (IIMOS)

04/09/2015
02/07/2024
EU PAS number:
EUPAS10872
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

HUBINC06380-final protocol - December 2014

English (501.36 KB - PDF) View document
Updated protocol

hubin-c-06380-amended-protocol2_20FEB2018

First published: 22/02/2024
English (528.62 KB - PDF) View document
Study results
Study results

hubin-c-06380-final_CSR_abstract

English (619.43 KB - PDF) View document
Study report
Other information
Publications
Study publications
Renard E, Guerci B, Jeandidier N. Long-term safety and efficacy of intraperiton…
Renard E, Guerci B, Jeandidier N. Long-term safety and efficacy of intraperiton…
ENCePP Seal
Composition of steering group and observers

HUBINC06380_SC_Members

English (12.88 KB - PDF) View document